NCT04893421View on ClinicalTrials.gov

Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 16, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2024

Conditions
Breast Neoplasm
Interventions
DEVICE

MOLLI Localization

Patients will be implanted with a MOLLI seed using a specialized introducer needle under imaging guidance. A special handhold probe and detection system will be used intraoperatively to assist in excision.

Trial Locations (1)

M4N-3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

collaborator

North York General Hospital

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER